loading

Finanzdaten der Cassava Sciences Inc-Aktie (SAVA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
84.63%
45.39
24.59 30.62 61.40 19.93
Operating Income/Loss
84.63%
-45.39
-24.59 -30.62 -61.40 -19.93
Income/Loss From Continuing Operations Before Tax
88.97%
-44.22
-23.40 -27.94 6.155 25.04
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
88.97%
-44.22
-23.40 -27.94 6.155 25.04
Net Income/Loss
88.97%
-44.22
-23.40 -27.94 6.155 25.04
Preferred Stock Dividends And Other Adjustments
-
- - - 43.79
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.10%
48.31
48.26 47.98 46.20 43.00
Diluted Average Shares
0.10%
48.31
48.26 47.98 46.20 44.10
Basic Earnings Per Share
91.67%
-0.92
-0.48 -0.58 0.13 0.58
Diluted Earnings Per Share
91.67%
-0.92
-0.48 -0.58 0.13 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):